Supplementary Agreement to the License Agreement dated September 1, 2006 between Aetas and NovaCardiaSupplementary Agreement • May 23rd, 2007 • NovaCardia Inc • Pharmaceutical preparations
Contract Type FiledMay 23rd, 2007 Company IndustryWith reference to the license agreement ("License Agreement") for K201 dated September 1, 2006 by and between Aetas Pharma Co., Ltd. ("Licensor") and NovaCardia Inc. ("Licensee"), Licensor and Licensee hereby enter into this Supplementary Agreement ("Supplementary Agreement") as of January 5, 2007 in order to supplement and amend the License Agreement to incorporate the Products for oral administration further to the existing intravenous administration.
Supplementary Agreement to the License Agreement dated September 1, 2006 between Aetas and NovaCardiaSupplementary Agreement • March 29th, 2007 • NovaCardia Inc
Contract Type FiledMarch 29th, 2007 CompanyWith reference to the license agreement ("License Agreement") for K201 dated September 1, 2006 by and between Aetas Pharma Co., Ltd. ("Licensor") and NovaCardia Inc. ("Licensee"), Licensor and Licensee hereby enter into this Supplementary Agreement ("Supplementary Agreement") as of January 5, 2007 in order to supplement and amend the License Agreement to incorporate the Products for oral administration further to the existing intravenous administration.